×
ModivCare Free Cash Flow 2010-2024 | MODV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Current Ratio
Quick Ratio
Debt/Equity Ratio
ROE
ROA
ROI
Return Tangible Eq
ModivCare free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Annual Chart
Annual % Change
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$84.8B
Cencora (COR)
$43.4B
DiDi Global (DIDIY)
$23B
Natera (NTRA)
$21.2B
ICON (ICLR)
$17.5B
Viatris (VTRS)
$14.8B
Avantor (AVTR)
$14.4B
Revvity (RVTY)
$13.6B
BioMerieux (BMXMF)
$12.3B
CochLear (CHEOY)
$11.9B
Solventum (SOLV)
$11.4B
Medpace Holdings (MEDP)
$10.4B
Doximity (DOCS)
$10B
Charles River Laboratories (CRL)
$9.3B
HealthEquity (HQY)
$8.4B
Sonic Healthcare (SKHHY)
$8.1B
Bausch + Lomb (BLCO)
$6.3B
Amplifon S.p.A (AMFPF)
$5.9B
Sotera Health (SHC)
$3.9B
Organon (OGN)
$3.9B
BrightSpring Health Services (BTSG)
$3B
Surgery Partners (SGRY)
$2.7B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.4B
Alignment Healthcare (ALHC)
$2.2B
GeneDx Holdings (WGS)
$2.2B
Premier (PINC)
$2.1B
PACS (PACS)
$2B
GoodRx Holdings (GDRX)
$1.7B
Ryman Healthcare (RYHTY)
$1.7B